USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
U.S Emerging Prostate Cancer Therapeutics Market
U.S Emerging Prostate Cancer Therapeutics Market
RELEASE DATE
22-Aug-2001
22-Aug-2001
REGION
North America
North America
Research Code: A053-01-00-00-00
SKU: HC00787-NA-MR_04456
$2,450.00
In stock
SKU
HC00787-NA-MR_04456
Description
This report on the U.S. Emerging Prostate Cancer Therapeutics Market gives detailed information about revenue forecasts, market shares, projected prevalence of disease and therapeutic options according to disease stage, namely localized, locally advanced, and metastatic prostate cancer. Key market and technology trends are discussed relative to the future of the market. The report also covers market drivers and restraints, major challenges facing the industry and offers strategies to address these challenges.
Table of Contents
Market Overview
- Introduction
Overview
- Scope and Segmentation
- Epidemiology and Etiology
- Staging of Prostate Cancer
- Market Trends
- Technology Trends- Gene Therapy
- Technology Trends- Others
Market Dynamics
- Top Three Challenges
- Challenges - Others
- Top Three Drivers
- Drivers - Others
- Top Three Restraints
- Restraints - Others
Strategic Recommendations
- Strategies Overview
- Strategic Recommendations for Market Challenge 1
- Strategic Recommendations for Market Challenge 2
- Strategic Recommendations for Market Challenge 3
- Strategic Recommendations for Market Challenge 4
- Strategic Recommendations for Market Challenge 5
- Strategic Recommendations for Market Challenge 6
Frost & Sullivan Market Engineering Awards
- Technology Innovation Award : Dendreon Corporation
- Strategic Alliance Leadership : Praecis Pharmaceuticals
- Technology Leadership : Medarex Inc.
- Website Leadership : Ilex Oncology
- Entrepreneurial Company : Cytran
Overview
Forecasts and Trends
Competitive Analysis
Overview
Forecasts and Trends
Competitive Analysis
Overview
Forecasts and Trends
Competitive Analysis
Popular Topics
This report on the U.S. Emerging Prostate Cancer Therapeutics Market gives detailed information about revenue forecasts, market shares, projected prevalence of disease and therapeutic options according to disease stage, namely localized, locally advanced, and metastatic prostate cancer. Key market and technology trends are discussed relative to the future of the market. The report also covers market drivers and restraints, major challenges facing the industry and offers strategies to address these challenges.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | A053-01-00-00-00 |
| Is Prebook | No |